NASDAQ:BHST - Nasdaq - CA09076J2074 - Common Stock - Currency: USD
Adma Biologics (ADMA) delivered earnings and revenue surprises of -12.50% and 3.61%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: ADMA
Ginkgo Bioworks (DNA) delivered earnings and revenue surprises of -28.46% and 17.12%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: DNA
BioHarvest Sciences Inc. (BHST) delivered earnings and revenue surprises of -41.67% and 1.05%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MDXG
BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.